ERYTECH announces plans to conduct registered initial public offering in the United States admERY July 28, 2015 Newsroom ERYTECH today announced that the Company plans to conduct a registered initial public offering in the United States. You Might Also Like ERYTECH announces data presentations at the American Society of Hematology 57th Annual Meeting November 5, 2015 ERYTECH receives authorization to start its Phase II clinical study in pancreatic cancer May 6, 2014 ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event January 4, 2021
ERYTECH announces data presentations at the American Society of Hematology 57th Annual Meeting November 5, 2015
ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event January 4, 2021
